Stock traders buy large volume of put options on Humana (NYSE: HUM)
Humana Inc. (NYSE: HUM) was the target of unusually heavy options trading activity on Friday. Traders bought 3,495 puts on the company. This represents a 65% increase over the average daily volume of 2,114 puts.
HUM has been the subject of several research reports. Citigroup raised its price target for Humana shares from $ 510.00 to $ 528.00 and assigned a “buy” rating to the stock in a research report on Tuesday, November 9. Royal Bank of Canada raised its price target for Humana shares from $ 479.00 to $ 525.00 and assigned the stock an “outperformance” rating in a research report released on Thursday, November 4. Oppenheimer raised its price target on Humana shares from $ 480.00 to $ 510.00 and rated the stock as “outperforming” in a research report released Thursday, November 4. Bank of America raised its price target for Humana shares from $ 505.00 to $ 530.00 and gave the company a “buy” rating in a research report released Thursday, November 4. Finally, the Goldman Sachs group assumed coverage of Humana’s shares in a research report on Tuesday, December 14. They issued a “neutral” rating and a target price of $ 472.00 on the stock. Seven investment analysts rated the stock with a conservation rating and thirteen gave the stock a buy rating. Based on data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus price target of $ 498.93.
In other Humana news, CEO Bruce D. Broussard sold 50,006 shares of the company in a trade on Friday, November 5. The shares were sold for an average price of $ 454.70, for a total value of $ 22,737,728.20. The transaction was disclosed in a legal file with the Securities & Exchange Commission, accessible through this hyperlink. Company insiders own 0.40% of the company’s shares.
Several institutional investors have recently changed their holdings in HUM. Viking Global Investors LP increased its position in Humana by 411.2% during the 3rd quarter. Viking Global Investors LP now owns 3,007,133 shares of the insurance provider valued at $ 1,170,226,000 after purchasing an additional 2,418,848 shares in the last quarter. FMR LLC increased its position in Humana by 18.7% during the 2nd quarter. FMR LLC now owns 10,241,494 shares of the insurance provider valued at $ 4,534,114,000 after purchasing an additional 1,612,251 shares during the last quarter. Amundi took a new stake in Humana during the second quarter for a value of approximately $ 393,330,000. Wellington Management Group LLP increased its position in Humana by 10.7% during the 3rd quarter. Wellington Management Group LLP now owns 6,465,032 shares of the insurance provider valued at $ 2,515,867,000 after purchasing an additional 626,652 shares in the last quarter. Finally, First Trust Advisors LP increased its position in Humana by 186.1% during the second quarter. First Trust Advisors LP now owns 690,050 shares of the insurance provider valued at $ 305,499,000 after purchasing an additional 448,859 shares in the last quarter. Institutional investors hold 91.75% of the company’s shares.
NYSE: HUM traded down $ 13.29 during Friday’s midday session, reaching $ 354.24. 61,433 shares of the stock traded hands, up from its average volume of 2,412,183. The company has a fifty-day moving average of $ 446.92 and a 200-day moving average of $ 434.17. Humana has a 12 month low of $ 359.28 and a 12 month high of $ 475.44. The company has a debt to equity ratio of 0.70, a quick ratio of 1.72, and a current ratio of 1.72. The stock has a market cap of $ 45.53 billion, a P / E ratio of 17.38, a PEG ratio of 1.68 and a beta of 0.94.
Humana (NYSE: HUM) last released its quarterly results on Wednesday, November 3. The insurance provider reported EPS of $ 4.83 for the quarter, beating the Zacks’ consensus estimate of $ 4.61 by $ 0.22. Humana had a net margin of 3.30% and a return on equity of 14.95%. The company posted revenue of $ 20.70 billion in the quarter, compared to $ 20.91 billion according to analysts’ estimates. During the same period of the previous year, the company posted EPS of $ 3.08. The company’s revenue increased 3.1% compared to the same quarter last year. On average, analysts predict that Humana will post 20.54 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 28. Shareholders of record on Friday, December 31 will receive a dividend of $ 0.70. The ex-dividend date for this dividend is Thursday, December 30. This represents an annualized dividend of $ 2.80 and a return of 0.79%. Humana’s dividend payout ratio (DPR) is currently 13.52%.
Humana Inc is engaged in the provision of health insurance services. The company operates in the following segments: retail, group and specialty services, and healthcare. The Retail segment includes products sold at retail to individuals, including medical and extended benefit plans such as Medicare and state-based Medicaid contracts.
See also: Crypto-currencies
This instant news alert was powered by storytelling technology and financial data from MarketBeat to provide readers with the fastest, most accurate reports. This story was reviewed by the MarketBeat editorial team before publication. Please send any questions or comments about this story to [email protected]
Should you invest $ 1,000 in Humana now?
Before you consider Humana, you’ll want to hear this.
MarketBeat tracks Wall Street’s top-rated and top-performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat identified the top five stocks that top analysts quietly whisper to their clients to buy now before the broader market takes hold of… and Humana was not on the list.
While Humana currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better bets.
See the 5 actions here